What to consider before prescribing inhaled medications: a pragmatic approach for evaluating the current inhaler landscape

Publikation: Bidrag til tidsskrift/Konferencebidrag i tidsskrift /Bidrag til avisReviewForskningpeer review

DOI

  • Federico Lavorini, Careggi Univ Hosp, University of Florence, Azienda Ospedaliero Universitaria Careggi, Dept Expt & Clin Med
  • ,
  • Christer Janson, Uppsala Univ, Uppsala University, Uppsala University Hospital, Dept Med Sci Resp Allergy & Sleep Res, Akad Sjukhuset
  • ,
  • Fulvio Braido, Univ Genoa, University of Genoa, IRCCS AOU San Martino IST, IRCCS, Allergy & Resp Dis Clin, DIMI,AOU San Martino IST
  • ,
  • Georgios Stratelis, Astraallen, AstraZeneca, AstraZeneca Nord Balt
  • ,
  • Anders Lokke

Inhaled therapies are the cornerstone of treatment in asthma and chronic obstructive pulmonary disease, and there are a multitude of devices available. There is, however, a distinct lack of evidence-based guidance for healthcare providers on how to choose an appropriate inhaler. This review aims to summarise recent updates on topics related to inhaler choice, and to offer practical considerations for healthcare providers regarding currently marketed devices. The importance of choosing the right inhaler for the right patient is discussed, and the relative merits of dry powder inhalers, pressurised metered dose inhalers, breath-actuated pressurised metered dose inhalers, spacers and soft mist inhalers are considered. Compiling the latest studies in the devices therapy area, this review focuses on the most common types of handling errors, as well as the comparative rates of incorrect inhalation technique between devices. The impact of device-specific handling errors on inhaler performance is also discussed, and the characteristics that can impair optimal drug delivery, such as inhalation flow rate, inhalation volume and particle size, are compared between devices. The impact of patient perceptions, behaviours and problems with inhalation technique is analysed, and the need for appropriate patient education is also highlighted. The continued development of technology in inhaler design and the need to standardise study assessment, endpoints and patient populations are identified as future research needs. The reviews of this paper are available via the supplemental material section.

OriginalsprogEngelsk
TidsskriftTherapeutic advances in respiratory disease
Vol/bind13
Antal sider28
ISSN1753-4658
DOI
StatusUdgivet - nov. 2019

Se relationer på Aarhus Universitet Citationsformater

ID: 189776555